Peptron, Inc. Logo

Peptron, Inc.

087010.KQ

(0.0)
Stock Price

51.200,00 KRW

-30.61% ROA

-37.78% ROE

-37.25x PER

Market Cap.

664.887.576.650,00 KRW

0% DER

0% Yield

-477.1% NPM

Peptron, Inc. Stock Analysis

Peptron, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Peptron, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Peptron, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Peptron, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Peptron, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Peptron, Inc. Revenue
Year Revenue Growth
2012 3.100.534.000
2013 3.103.476.720 0.09%
2014 2.483.532.220 -24.96%
2015 2.812.386.770 11.69%
2016 3.130.705.300 10.17%
2017 3.215.383.990 2.63%
2018 3.861.733.210 16.74%
2019 1.801.118.520 -114.41%
2020 3.120.697.700 42.28%
2021 6.624.511.950 52.89%
2022 5.813.995.530 -13.94%
2023 2.781.412.360 -109.03%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Peptron, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2012 765.119.000
2013 1.918.242.000 60.11%
2014 1.990.923.000 3.65%
2015 2.006.115.000 0.76%
2016 2.771.481.000 27.62%
2017 3.737.128.000 25.84%
2018 6.069.266.000 38.43%
2019 9.835.210.000 38.29%
2020 14.179.995.000 30.64%
2021 14.841.564.000 4.46%
2022 13.367.267.000 -11.03%
2023 12.882.084.000 -3.77%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Peptron, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 17.952.000
2013 22.222.000 19.22%
2014 1.049.140.970 97.88%
2015 1.104.348.160 5%
2016 1.307.840.870 15.56%
2017 1.613.761.820 18.96%
2018 2.521.548.810 36%
2019 2.649.698.890 4.84%
2020 2.844.441.540 6.85%
2021 3.369.953.380 15.59%
2022 3.445.446.000 2.19%
2023 4.323.508.480 20.31%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Peptron, Inc. EBITDA
Year EBITDA Growth
2012 -186.827.000
2013 -1.378.069.730 86.44%
2014 -2.030.862.170 32.14%
2015 -2.252.234.960 9.83%
2016 -2.961.957.390 23.96%
2017 -4.179.616.000 29.13%
2018 -7.006.172.930 40.34%
2019 -10.052.453.640 30.3%
2020 -14.339.715.700 29.9%
2021 -12.148.869.760 -18.03%
2022 -10.172.249.750 -19.43%
2023 -15.141.314.720 32.82%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Peptron, Inc. Gross Profit
Year Gross Profit Growth
2012 974.956.000
2013 1.330.951.170 26.75%
2014 1.093.319.800 -21.73%
2015 873.630.200 -25.15%
2016 1.199.241.480 27.15%
2017 1.163.611.820 -3.06%
2018 1.391.363.880 16.37%
2019 567.068.250 -145.36%
2020 1.009.751.841 43.84%
2021 4.466.324.620 77.39%
2022 3.270.681.250 -36.56%
2023 870.929.760 -275.54%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Peptron, Inc. Net Profit
Year Net Profit Growth
2012 -2.559.474.000
2013 -2.059.418.400 -24.28%
2014 -3.046.281.250 32.4%
2015 -2.733.583.000 -11.44%
2016 -3.190.976.520 14.33%
2017 -4.426.816.810 27.92%
2018 -3.725.911.560 -18.81%
2019 -17.717.556.530 78.97%
2020 -18.381.915.480 3.61%
2021 -15.041.985.210 -22.2%
2022 -15.062.789.630 0.14%
2023 -18.032.457.960 16.47%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Peptron, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 -831
2013 -662 -25.53%
2014 -864 23.38%
2015 -505 -71.43%
2016 -565 10.8%
2017 -305 -85.25%
2018 -243 -25.51%
2019 -1.156 78.98%
2020 -1.196 3.34%
2021 -729 -64.06%
2022 -730 0.14%
2023 -876 16.57%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Peptron, Inc. Free Cashflow
Year Free Cashflow Growth
2012 -1.097.578.000
2013 -1.381.993.600 20.58%
2014 -3.465.317.790 60.12%
2015 -2.605.197.390 -33.02%
2016 -5.514.690.030 52.76%
2017 -27.471.156.110 79.93%
2018 -14.315.759.440 -91.89%
2019 -14.606.305.260 1.99%
2020 -16.648.271.140 12.27%
2021 -11.313.397.130 -47.16%
2022 -13.244.815.360 14.58%
2023 -3.653.557.160 -262.52%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Peptron, Inc. Operating Cashflow
Year Operating Cashflow Growth
2012 -958.521.000
2013 -1.319.803.030 27.37%
2014 -2.856.433.460 53.8%
2015 -2.355.852.690 -21.25%
2016 -2.729.800.630 13.7%
2017 -5.625.535.860 51.47%
2018 -4.180.119.820 -34.58%
2019 -9.599.502.080 56.45%
2020 -13.550.207.790 29.16%
2021 -10.614.800.220 -27.65%
2022 -11.719.975.870 9.43%
2023 -3.392.135.160 -245.5%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Peptron, Inc. Capital Expenditure
Year Capital Expenditure Growth
2012 139.057.000
2013 62.190.570 -123.6%
2014 608.884.330 89.79%
2015 249.344.700 -144.19%
2016 2.784.889.400 91.05%
2017 21.845.620.250 87.25%
2018 10.135.639.620 -115.53%
2019 5.006.803.180 -102.44%
2020 3.098.063.350 -61.61%
2021 698.596.910 -343.47%
2022 1.524.839.490 54.19%
2023 261.422.000 -483.29%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Peptron, Inc. Equity
Year Equity Growth
2012 5.336.118.000
2013 -4.331.180.420 223.2%
2014 7.181.100.050 160.31%
2015 17.227.638.200 58.32%
2016 53.208.771.150 67.62%
2017 48.945.102.330 -8.71%
2018 45.098.347.820 -8.53%
2019 28.086.012.600 -60.57%
2020 77.133.204.640 63.59%
2021 62.282.790.570 -23.84%
2022 53.109.372.080 -17.27%
2023 44.024.651.410 -20.64%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Peptron, Inc. Assets
Year Assets Growth
2012 15.830.697.000
2013 6.679.844.360 -136.99%
2014 11.576.005.320 42.3%
2015 21.656.402.320 46.55%
2016 57.901.628.990 62.6%
2017 53.048.615.400 -9.15%
2018 71.758.901.730 26.07%
2019 60.985.838.280 -17.66%
2020 117.701.410.320 48.19%
2021 77.868.953.810 -51.15%
2022 68.274.569.619 -14.05%
2023 59.076.382.040 -15.57%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Peptron, Inc. Liabilities
Year Liabilities Growth
2012 10.494.579.000
2013 11.011.024.780 4.69%
2014 4.394.905.280 -150.54%
2015 2.911.891.420 -50.93%
2016 4.692.857.840 37.95%
2017 4.103.513.079 -14.36%
2018 26.660.553.910 84.61%
2019 32.899.825.680 18.96%
2020 40.568.205.680 18.9%
2021 15.586.163.240 -160.28%
2022 15.165.197.540 -2.78%
2023 15.051.730.640 -0.75%

Peptron, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
188.44
Net Income per Share
-868.52
Price to Earning Ratio
-37.25x
Price To Sales Ratio
171.38x
POCF Ratio
-55.4
PFCF Ratio
-51.15
Price to Book Ratio
15.13
EV to Sales
169.69
EV Over EBITDA
-51.25
EV to Operating CashFlow
-54.76
EV to FreeCashFlow
-50.64
Earnings Yield
-0.03
FreeCashFlow Yield
-0.02
Market Cap
664,89 Bil.
Enterprise Value
658,31 Bil.
Graham Number
6464.31
Graham NetNet
-222.12

Income Statement Metrics

Net Income per Share
-868.52
Income Quality
0.67
ROE
-0.36
Return On Assets
-0.3
Return On Capital Employed
-0.32
Net Income per EBT
1
EBT Per Ebit
0.94
Ebit per Revenue
-5.1
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
1.03
Research & Developement to Revenue
3.4
Stock Based Compensation to Revenue
0
Gross Profit Margin
-0.16
Operating Profit Margin
-5.1
Pretax Profit Margin
-4.77
Net Profit Margin
-4.77

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-583.96
Free CashFlow per Share
-631.38
Capex to Operating CashFlow
0.08
Capex to Revenue
-0.25
Capex to Depreciation
-0.2
Return on Invested Capital
-0.4
Return on Tangible Assets
-0.31
Days Sales Outstanding
29.43
Days Payables Outstanding
28.86
Days of Inventory on Hand
16.97
Receivables Turnover
12.4
Payables Turnover
12.65
Inventory Turnover
21.51
Capex per Share
-47.42

Balance Sheet

Cash per Share
494,52
Book Value per Share
2.138,38
Tangible Book Value per Share
2106.12
Shareholders Equity per Share
2138.38
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0.51
Current Ratio
1.45
Tangible Asset Value
43,36 Bil.
Net Current Asset Value
0,03 Bil.
Invested Capital
0
Working Capital
4,66 Bil.
Intangibles to Total Assets
0.01
Average Receivables
0,33 Bil.
Average Payables
0,33 Bil.
Average Inventory
199479325
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Peptron, Inc. Dividends
Year Dividends Growth
2022 0

Peptron, Inc. Profile

About Peptron, Inc.

Peptron, Inc. engages in the development of peptide-based medicines to treat chronic diseases. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, and puberty; SR-Octreotide (PT201) for the treatment of acromegaly; SR-Exenatide (PT302) to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.

CEO
Mr. Ho-Il Choi
Employee
94
Address
37-24, Yuseong-daero 1628 beon-gil
Daejeon, 340-54

Peptron, Inc. Executives & BODs

Peptron, Inc. Executives & BODs
# Name Age
1 Mr. Ho-Il Choi
Chief Executive Officer
70

Peptron, Inc. Competitors